Arteriosclerosis and Thrombosis, Vol 11, 64-70, Copyright © 1991 by American Heart Association
ARTICLES |
M Dobiasova, J Stribrna, DL Sparks, PH Pritchard and JJ Frohlich
Institute of Nuclear Biology and Radiochemistry, Czechoslovak Academy of Sciences, Prague.
The fractional rate of cholesterol esterification in very low density lipoprotein- and low density lipoprotein-depleted plasma (FERHDL) was studied in normolipidemic subjects and in individuals with hyperlipidemia and proven coronary artery disease (CAD). The FERHDL was significantly higher than the FER in whole plasma and was significantly higher in normal men than in normal women. In addition, men and women with primary hyperlipidemia had significantly higher FERHDL values relative to their sex-matched controls. The most significant increases in FERHDL values, however, were observed in individuals with CAD. In all patient groups, FERHDL was positively correlated with plasma triglyceride concentration. In addition, FERHDL was negatively related to plasma high density lipoprotein (HDL) cholesterol concentration in all groups except in men with CAD and in normolipidemic women. The gradient gel electrophoretic pattern of HDL from individuals with either low or high FERHDL values indicated an inverse relation between this activity and the relative amount of HDL2b particles. FERHDL likely reflects the metabolic properties of the heterogeneous population of HDL particles in the plasma and may be a function of the relative content of larger and smaller HDL particles. It appears to be a sensitive and reliable functional measure of the particle size distribution in the HDL pool and one of potential clinical value in the assessment of risk for CAD.
This article has been cited by other articles:
![]() |
M. H. Tan, D. Johns, and N. B. Glazer Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes Clin. Chem., July 1, 2004; 50(7): 1184 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frohlich and M. Dobiasova Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography Clin. Chem., November 1, 2003; 49(11): 1873 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Santos, W. Hueb, A. A. Oliveira, J. A. F. Ramires, and R. C. Maranhao Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease J. Lipid Res., March 1, 2003; 44(3): 464 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Skeggs and R. E. Morton LDL and HDL enriched in triglyceride promote abnormal cholesterol transport J. Lipid Res., August 1, 2002; 43(8): 1264 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. MOGHADASIAN, B. M. McMANUS, L. B. NGUYEN, S. SHEFER, M. NADJI, D. V. GODIN, T. J. GREEN, J. HILL, Y. YANG, C. H. SCUDAMORE, et al. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans FASEB J, December 1, 2001; 15(14): 2623 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Brown, X.-Q. Zhao, A. Chait, L. D. Fisher, M. C. Cheung, J. S. Morse, A. A. Dowdy, E. K. Marino, E. L. Bolson, P. Alaupovic, et al. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease N. Engl. J. Med., November 29, 2001; 345(22): 1583 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. McGladdery and J. J. Frohlich Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy J. Lipid Res., November 1, 2001; 42(11): 1905 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Stamler, D. Breznan, T. A-M. Neville, F. J. Viau, E. Camlioglu, and D. L. Sparks Phosphatidylinositol promotes cholesterol transport in vivo J. Lipid Res., August 1, 2000; 41(8): 1214 - 1221. [Abstract] [Full Text] |
||||
![]() |
M. Dobiásová, L. Adler, T. Ohta, and J. Frohlich Effect of labeling of plasma lipoproteins with [3H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma J. Lipid Res., August 1, 2000; 41(8): 1356 - 1357. [Abstract] [Full Text] |
||||
![]() |
D. C. McManus, B. R. Scott, P. G. Frank, V. Franklin, J. R. Schultz, and Y. L. Marcel Distinct Central Amphipathic alpha -Helices in Apolipoprotein A-I Contribute to the in Vivo Maturation of High Density Lipoprotein by Either Activating Lecithin-Cholesterol Acyltransferase or Binding Lipids J. Biol. Chem., February 18, 2000; 275(7): 5043 - 5051. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saku, B. Zhang, T. Ohta, and K. Arakawa Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis J. Am. Coll. Cardiol., February 1, 1999; 33(2): 436 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Argyropoulos, A. Jenkins, R. L. Klein, T. Lyons, B. Wagenhorst, J. St. Armand, S. M. Marcovina, J. J. Albers, P. H. Pritchard, and W. T. Garvey Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure–function relationships and studies in a compound heterozygous proband J. Lipid Res., September 1, 1998; 39(9): 1870 - 1876. [Abstract] [Full Text] |
||||
![]() |
M. H. Moghadasian, B. M. McManus, P. H. Pritchard, and J. J. Frohlich "Tall Oil"–Derived Phytosterols Reduce Atherosclerosis in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 119 - 126. [Abstract] [Full Text] |
||||
![]() |
J. Hasler-Rapacz, H. J. Kempen, H. M.G. Princen, B. J. Kudchodkar, A. Lacko, and J. Rapacz Effects of Simvastatin on Plasma Lipids and Apolipoproteins in Familial Hypercholesterolemic Swine Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 137 - 143. [Abstract] [Full Text] |
||||
![]() |
D. L. Sparks, W. S. Davidson, S. Lund-Katz, and M. C. Phillips Effects of the Neutral Lipid Content of High Density Lipoprotein on Apolipoprotein A-I Structure and Particle Stability J. Biol. Chem., November 10, 1995; 270(45): 26910 - 26917. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murakami, S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1819 - 1828. [Abstract] [Full Text] |
||||
![]() |
K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1866 - 1874. [Abstract] [Full Text] |
||||
![]() |
T. Ohta, K. Saku, K. Takata, R. Nakamura, Y. Ikeda, and I. Matsuda Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 956 - 962. [Abstract] [Full Text] |
||||
![]() |
D. L. Sparks, G. M. Anantharamaiah, J. P. Segrest, and M. C. Phillips Effect of the Cholesterol Content of Reconstituted LpA-I on Lecithin:Cholesterol Acyltransferase Activity J. Biol. Chem., March 10, 1995; 270(10): 5151 - 5157. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |